Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells

B. Renouf, E. Hollville, A. Pujals, C. Tétaud, J. Garibal, J. Wiels*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

25 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells'. Together they form a unique fingerprint.

Medicine & Life Sciences